{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T16:00:17Z","timestamp":1790870417611,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jconrel.2022.08.016","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T06:10:58Z","timestamp":1660803058000},"page":"146-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Electrospun patch delivery of anti-TNF\u03b1 F(ab) for the treatment of inflammatory oral mucosal disease"],"prefix":"10.1016","volume":"350","author":[{"given":"Jake G.","family":"Edmans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Ollington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Colley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin E.","family":"Santocildes-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Siim Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul V.","family":"Hatton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian G.","family":"Spain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Murdoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.08.016_bb0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bjoms.2007.07.201","article-title":"Oral mucosal disease: recurrent aphthous stomatitis","volume":"46","author":"Scully","year":"2008","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0010","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/odi.13323","article-title":"Worldwide prevalence of oral lichen planus: a systematic review and meta-analysis","volume":"27","author":"Gonz\u00e1lez-Moles","year":"2021","journal-title":"Oral Dis."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0714.1992.tb00963.x","article-title":"Increased production of tumour necrosis factor by peripheral blood leukocytes in patients with recurrent oral aphthous ulceration","volume":"21","author":"Taylor","year":"1992","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0020","article-title":"Immune mechanisms in oral lichen planus","volume":"0\u20133","author":"El-Howati","year":"2022","journal-title":"Oral Dis."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0025","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bjoms.2007.07.199","article-title":"Oral mucosal disease: lichen planus","volume":"46","author":"Scully","year":"2008","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0030","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.clindermatol.2009.03.004","article-title":"Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies","volume":"28","author":"Farhi","year":"2010","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcell.2020.00401","article-title":"Selective targeting of TNF receptors as a novel therapeutic approach","volume":"8","author":"Fischer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0040","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.bdj.2015.439","article-title":"Biological agents: what they are, how they affect oral health and how they can modulate oral healthcare","volume":"218","author":"Georgakopoulou","year":"2015","journal-title":"Br. Dent. J."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/odi.12634","article-title":"Interventions for the management of oral lichen planus: a review of the conventional and novel therapies","volume":"23","author":"Gupta","year":"2017","journal-title":"Oral Dis."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0050","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1601-0825.2011.01793.x","article-title":"Local drug delivery for oral mucosal diseases: challenges and opportunities","volume":"17","author":"Sankar","year":"2011","journal-title":"Oral Dis."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1601-0825.2012.01931.x","article-title":"Biologics in oral medicine: ulcerative disorders","volume":"19","author":"O\u2019Neill","year":"2013","journal-title":"Oral Dis."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1742-481X.2006.00233.x","article-title":"Topical application of the tumour necrosis factor-\u03b1 antibody infliximab improves healing of chronic wounds","volume":"3","author":"Streit","year":"2006","journal-title":"Int. Wound J."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2341\/08-3","article-title":"The role of chlorhexidine in caries prevention","volume":"33","author":"Autio-Gold","year":"2008","journal-title":"Oper. Dent."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0885-3924(02)00524-9","article-title":"Efficacy of gelclair in reducing pain in palliative care patients with oral lesions","volume":"24","author":"Innocenti","year":"2002","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/cncr.23152","article-title":"Comparison of the efficacy and safety of miconazole 50-mg mucoadhesive buccal tablets with miconazole 500-mg gel in the treatment of oropharyngeal candidiasis: a prospective, randomized, single-blind, multicenter, comparative, phase III trial in patients","volume":"112","author":"Bensadoun","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0080","doi-asserted-by":"crossref","first-page":"11557","DOI":"10.1021\/acsami.7b02337","article-title":"Fabrication of electrospun mucoadhesive membranes for therapeutic applications in oral medicine","volume":"9","author":"Santocildes-Romero","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics12060504","article-title":"Mucoadhesive electrospun fibre-based technologies for oral medicine","volume":"12","author":"Edmans","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0090","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biomaterials.2018.06.009","article-title":"Pre-clinical evaluation of novel mucoadhesive bilayer patches for local delivery of clobetasol-17-propionate to the oral mucosa","volume":"178","author":"Colley","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0095","first-page":"0","article-title":"Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus","author":"Brennan","year":"2021","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.110917","article-title":"Incorporation of lysozyme into a mucoadhesive electrospun patch for rapid protein delivery to the oral mucosa","volume":"112","author":"Edmans","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0110","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"PBMCs","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/marc.201400516","article-title":"Strong fluorescence of poly (N-vinylpyrrolidone) and its oxidized hydrolyzate","volume":"36","author":"Song","year":"2015","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0120","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.4049\/jimmunol.178.11.7405","article-title":"Expression of Tie-2 by human monocytes and their responses to angiopoietin-2","volume":"178","author":"Murdoch","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0125","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1089\/ten.tec.2021.0124","article-title":"Immunoresponsive tissue-engineered oral mucosal equivalents containing macrophages","volume":"27","author":"Ollington","year":"2021","journal-title":"Tissue Eng. - Part C Methods"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1023\/A:1018903624373","article-title":"The stabilization of a human IgM monoclonal antibody with poly(vinylpyrrolidone)","volume":"11","author":"Gombotz","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0135","doi-asserted-by":"crossref","first-page":"12108","DOI":"10.1016\/S0021-9258(18)43240-1","article-title":"Mechanism of precipitation of proteins by polyethylene glycols. Analysis in terms of excluded volume","volume":"256","author":"Atha","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0140","doi-asserted-by":"crossref","first-page":"6984","DOI":"10.1021\/bi100727y","article-title":"Volume exclusion and soft interaction effects on protein stability under crowded conditions","volume":"49","author":"Miklos","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/mp800160p","article-title":"Mechanistic examination of protein release from polymer nanofibers","volume":"6","author":"Gandhi","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0150","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.actbio.2017.10.015","article-title":"Electrospun formulations of bevacizumab for sustained release in the eye","volume":"64","author":"Angkawinitwong","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.addr.2015.08.001","article-title":"Stabilization challenges and formulation strategies associated with oral biologic drug delivery systems","volume":"93","author":"Truong-Le","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0160","doi-asserted-by":"crossref","unstructured":"N. Simon, C. Sperber, C. Voigtl\u00e4nder, J. Born, D. F. Gilbert, S. Seyferth, G. Lee, B. Kappes and O. Friedrich, Improved stability of polyclonal antibodies: a case study with lyophilization-conserved antibodies raised against epitopes from the malaria parasite plasmodium falciparum, Eur. J. Pharm. Sci., DOI:https:\/\/doi.org\/10.1016\/j.ejps.2019.105086.","DOI":"10.1016\/j.ejps.2019.105086"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0165","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/1061186X.2019.1669043","article-title":"Protein drug delivery: current dosage form profile and formulation strategies","volume":"28","author":"Geraldes","year":"2020","journal-title":"J. Drug Target."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0170","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijpharm.2017.09.043","article-title":"Protein-loaded emulsion electrospun fibers optimized for bioactivity retention and pH-controlled release for peroral delivery of biologic therapeutics","volume":"533","author":"Frizzell","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0175","series-title":"Basic Histology","author":"Junqueira","year":"1995"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0180","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/193229680900300323","article-title":"Oral insulin and buccal insulin: a critical reappraisal","volume":"3","author":"Heinemann","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0185","doi-asserted-by":"crossref","first-page":"843","DOI":"10.2337\/diacare.19.8.843","article-title":"Potential therapeutic levels of glucagon-like peptide I achieved in humans by a buccal tablet","volume":"19","author":"Gutniak","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21688370.2018.1479568","article-title":"Cell culture models of oral mucosal barriers: a review with a focus on applications, culture conditions and barrier properties","volume":"6","author":"Bierbaumer","year":"2018","journal-title":"Tissue Barriers"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0195","unstructured":"M. B. Stie, J. R. G\u00e4tke, I. S. Chronakis, J. Jacobsen and H. M. Nielsen, Mucoadhesive Electrospun Nanofiber-Based Hybrid System with Controlled and Unidirectional Release of Desmopressin."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0200","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1097-0290(20000205)67:3<253::AID-BIT1>3.0.CO;2-T","article-title":"Long-term vaginal antibody delivery: delivery systems and biodistribution","volume":"67","author":"Saltzman","year":"2000","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nbt0298-163","article-title":"Topical antibody delivery systems produce sustained levels in mucosal tissue and blood","volume":"16","author":"Kuo","year":"1998","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0215","unstructured":"R. K. Jain, Physiological barriers to delivery of monoclonal antibodies and other macromolecules in tumors, Cancer Res."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0220","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1089\/ten.tec.2016.0310","article-title":"Development and characterization of in vitro human oral mucosal equivalents derived from immortalized Oral keratinocytes","volume":"22","author":"Jennings","year":"2016","journal-title":"Tissue Eng. Part C Methods"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0225","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1016\/j.clim.2007.03.124","article-title":"TNF binding by certolizumab pegol, adalimumab, and infliximab-stoichiometry, complex formation, and the biologic effects of complexes","volume":"123","author":"Henry","year":"2007","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jop.12142","article-title":"Inflammation-related cytokines in oral lichen planus: an overview","volume":"44","author":"Lu","year":"2015","journal-title":"J. Oral Pathol. Med."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0235","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.4049\/jimmunol.172.5.2731","article-title":"Of mice and not men: differences between mouse and human immunology","volume":"172","author":"Mestas","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0240","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1177\/0022034511435702","article-title":"Tissue-engineered oral mucosa","volume":"91","author":"Moharamzadeh","year":"2012","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0245","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.micpath.2010.11.009","article-title":"Evaluation of tissue engineered models of the oral mucosa to investigate oral candidiasis","volume":"50","author":"Yadev","year":"2011","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0250","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/ten.tec.2016.0066","article-title":"Development of a full-thickness human gingiva equivalent constructed from immortalized keratinocytes and fibroblasts","volume":"22","author":"Buskermolen","year":"2016","journal-title":"Tissue Eng. - Part C Methods"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0255","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/bjc.2011.403","article-title":"Development of tissue-engineered models of oral dysplasia and early invasive oral squamous cell carcinoma","volume":"105","author":"Colley","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0260","doi-asserted-by":"crossref","first-page":"907","DOI":"10.3109\/09553002.2013.809171","article-title":"Tissue-engineered oral mucosa to study radiotherapy-induced oral mucositis","volume":"89","author":"Colley","year":"2013","journal-title":"Int. J. Radiat. Biol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0265","doi-asserted-by":"crossref","unstructured":"T. M. Ferrisse, A. B. de Oliveira, M. P. Pala\u00e7on, E. V. Silva, E. M. S. Massucato, L. Y. de Almeida, J. E. L\u00e9on and A. Bufalino, The role of CD68+ and CD163+ macrophages in immunopathogenesis of oral lichen planus and oral lichenoid lesions, Immunobiology, https:\/\/doi.org\/10.1016\/j.imbio.2021.152072.","DOI":"10.1016\/j.imbio.2021.152072"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0270","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4103\/0973-029X.86669","article-title":"Recurrent aphthous stomatitis","volume":"15","author":"Preeti","year":"2011","journal-title":"J. Oral Maxillofac. Pathol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0275","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10753-018-0934-0","article-title":"The expression of CXCL10\/CXCR3 and effect of the axis on the function of T lymphocyte involved in oral lichen planus","volume":"42","author":"Fang","year":"2019","journal-title":"Inflammation"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0280","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0285","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1182\/blood.V96.7.2584","article-title":"Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE","volume":"96","author":"Suzuki","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0290","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.4049\/jimmunol.159.10.5063","article-title":"Macrophage inflammatory protein-1 alpha production in lipopolysaccharide-stimulated human adherent blood mononuclear cells is inhibited by the nitric oxide synthase inhibitor N(G)-monomethyl-L-arginine","volume":"159","author":"M\u00fchl","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0295","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/1523-1747.ep12345482","article-title":"Epidermal and oral keratinocytes are induced to produce RANTES and IL-8 by cytokine stimulation","volume":"106","author":"Li","year":"1996","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1471-4906(00)01812-3","article-title":"RANTES: a versatile and controversial chemokine","volume":"22","author":"Appay","year":"2001","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jconrel.2022.08.016_bb0305","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3390\/pharmaceutics14030483","article-title":"Evaluation of a multifunctional polyvinylpyrrolidone\/hyaluronic acid-based bilayer film patch with anti-inflammatory properties as an enhancer of the wound healing process","volume":"14","author":"Contardi","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0310","article-title":"Anti-inflammatory effects of silver-polyvinyl pyrrolidone (Ag-PVP) nanoparticles in mouse macrophages infected with live chlamydia trachomatis","volume":"2421","author":"Dennis","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2022.08.016_bb0315","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ebiom.2018.07.035","article-title":"Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942","volume":"35","author":"Burgess","year":"2018","journal-title":"EBioMedicine"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200520X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592200520X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:26:58Z","timestamp":1759163218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592200520X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":63,"alternative-id":["S016836592200520X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Electrospun patch delivery of anti-TNF\u03b1 F(ab) for the treatment of inflammatory oral mucosal disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}